Update on GnRH in IVF - can we improve success?
Hilton Deansgate Hotel, Manchester
9th May 2008
Scientific Programme
09.30-10.00 Registration and coffee
10.00-10.15 Welcome and introduction (Luciano G. Nardo, Manchester)
Session I Chairman: John D. Aplin, Manchester
10.15-10.45 The use of AMH to determine treatment strategy in normal and high-responders
(Richard Fleming, Glasgow)
10.45-11.15 Oocyte and embryo quality in GnRH agonists and antagonists cycles
(Moncef Benkhalifa, France)
11.15-11.45 Endometrial development in oocyte donors treated with GnRH antagonists versus GnRH
agonist (Juan A. Garcia-Velasco, Spain)
11.45-12.00 Discussion
12.00-13.00 Lunch
Session II Chairman: Charles Kingsland, Liverpool
13.15-13.45 GnRH agonist and antagonist protocols (William L. Ledger, Sheffield)
13.45-14.15 Is live birth after IVF affected by the type of GnRH analogue used?
(Tim Cordes, Germany)
14.15-14.30 Discussion
14.30-15.00 Coffee break
Session III Chairman: Joo Thong, Edinburgh
15.30-16.45 Open discussion: what's the role of GnRH antagonists in assisted reproduction?
(All speakers)
16.45-17.00 Closing remarks (Luciano G. Nardo, Manchester)
